Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins

Journal of Immunological Methods

Volumn 329, Issue 1-2, 2008, Pages 92-101

  Jones, R G A ^a   Ochiai, M ^b   Liu, Y ^a   Ekong, T ^a   Sesardic, D ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Botulinum toxin; Endopeptidase; Endoprotease; Enzyme; Light chain; Neurotoxicity

Indexed keywords

ALBUMIN; ANTIBODY; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN C1; BOTULINUM TOXIN E; HEMAGGLUTININ; POLYSORBATE 20; PROTEINASE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; ENZYME ACTIVITY; IMMUNOASSAY; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SENSITIVITY AND SPECIFICITY;

ALBUMINS; ANTIBODIES; BLOTTING, WESTERN; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOENZYME TECHNIQUES; PEPTIDE FRAGMENTS; POLYSORBATES; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TEMPERATURE; TIME FACTORS; TROMETHAMINE;

EID: 36849053345     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.09.014     Document Type: Article

References (37)

1. Anne C., Cornille F., Lenoir C., and Roques B.P. High-throughput fluorogenic assay for determination of botulinum type B neurotoxin protease activity. Anal. Biochem. 291 (2001) 253
2. Avrameas S. Amplification systems in immunoenzymatic techniques. J. Immunol. Methods 150 (1992) 23
3. Bajohrs M., Rickman C., Binz T., and Davletov B. A molecular basis underlying differences in the toxicity of botulinum serotypes A and E. EMBO Rep. 5 (2004) 1090
4. Binz T., Blasi J., Yamasaki S., Baumeister A., Link E., Sudhof T.C., Jahn R., and Niemann H. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269 (1994) 1617
5. Blanes-Mira C., Ibanez C., Fernandez-Ballester G., Planells-Cases R., Perez-Paya E., and Ferrer-Montiel A. Thermal stabilization of the catalytic domain of botulinum neurotoxin E by phosphorylation of a single tyrosine residue. Biochemistry 40 (2001) 2234
6. Chao H.Y., Wang Y.C., Tang S.S., and Liu H.W. A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A. Toxicon 43 (2004) 27
7. Dekleva M.L., and Dasgupta B.R. Purification and characterization of a protease from Clostridium botulinum type A that nicks single-chain type A botulinum neurotoxin into the di-chain form. J. Bacteriol. 172 (1990) 2498
8. Demarchi J., Mourgues C., Orio J., and Prevot A.R. Existence of human botulism type D. Bull. Acad. Natl. Med. 142 (1958) 580
9. Dong M., Yeh F., Tepp W.H., Dean C., Johnson E.A., Janz R., and Chapman E.R. SV2 is the protein receptor for botulinum neurotoxin A. Science 312 (2006) 592
10. Ekong T.A., Mclellan K., and Sesardic D. Immunological detection of Clostridium botulinum toxin type A in therapeutic preparations. J. Immunol. Methods 180 (1995) 181
11. Ekong T.A., Feavers I.M., and Sesardic D. Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro. Microbiology 143 (1997) 3337
12. Gaines Das R.E., Heath A.B., Martin H., and Sesardic D. Validation of in vitro assays for botulinum toxin: a case study. Dev. Biol. Stand. 101 (1999) 267
13. Hallis B., James B.A., and Shone C.C. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities. J. Clin. Microbiol. 34 (1996) 1934
14. Ibanez C., Blanes-Mira C., Fernandez-Ballester G., Planells-Cases R., and Ferrer-Montiel A. Modulation of botulinum neurotoxin A catalytic domain stability by tyrosine phosphorylation. FEBS Lett. 578 (2004) 121
15. Jones R.G.A., Alsop T.A., Hull R., Tierney R., Rigsby P., Holley J., and Sesardic D. Botulinum type A toxin neutralisation by specific IgG and its fragments: A comparison of mouse systemic toxicity and local flaccid paralysis assays. Toxicon 48 (2006) 246
16. Kalb S.R., Moura H., Boyer A.E., McWilliams L.G., Pirkle J.L., and Barr J.R. The use of Endopep-MS for the detection of botulinum toxins A B, E, and F in serum and stool samples. Anal. Biochem. 351 (2006) 84
17. Kautter D.A., and Solomon H.M. Collaborative study of a method for the detection of Clostridium botulinum and its toxins in foods. J. Assoc. Off. Anal. Chem. 60 (1977) 541
18. Landon J., and Smith D.S. Merits of sheep antisera for antivenom manufacture. J. Toxicol., Toxin Rev. 22 (2003) 15
19. Lawrence G., Wang J., Chion C.K., Aoki K.R., and Dolly J.O. Two protein trafficking processes at motor nerve endings unveiled by botulinum neurotoxin E. J. Pharmacol. Exp. Ther. 320 (2007) 410
20. Montecucco C., Papini E., and Schiavo G. Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett. 346 (1994) 92
21. Ohishi I., Okada T., and Sakaguchi G. Responses of Clostridium botulinum type B and E progenitor toxins to some clostridial sulfhydryl-dependent proteases. Jpn. J. Med. Sci. Biol. 28 (1975) 157
22. PhEur monograph. Botulinum toxin type A for injection 01-2005:2113. European Pharmacopoeia 5.0.2. EDQM (2005) 1117
23. Prevot A.R., Terrasse J., Daumail J., Cavaroc M., Riol J., and Sillioc R. Existence of type C human botulism in France. Bull. Acad. Natl. Med. 139 (1955) 355
24. Schagger H., and von Jagow J.G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166 (1987) 368
25. Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino de L.P., Dasgupta B.R., and Montecucco C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359 (1992) 832
26. Schiavo G., Santucci A., Dasgupta B.R., Mehta P.P., Jontes J., Benfenati F., Wilson M.C., and Montecucco C. Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett. 335 (1993) 99
27. Schiavo G., Matteoli M., and Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80 (2000) 717
28. Schmidt J.J., and Stafford R.G. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F. Appl. Environ. Microbiol. 69 (2003) 297
29. Schmidt J.J., and Stafford R.G. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F (vol 69, pg 297, 2003). Appl. Environ. Microbiol. 69 (2003) 3025
30. Schmidt J.J., Stafford R.G., and Millard C.B. High-throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F. Anal. Biochem. 296 (2001) 130
31. Sesardic D., Corran P.H., Gee C., and Ekong T. In vitro approaches for estimating activity of tetanus toxin as an alternative assay for specific toxicity. In: Balls M., van Zeller A.-M., and Halder M.E. (Eds). Progress in the reduction, refinement and replacement of animal experimentation (2000), Elsevier Science 969
32. Sesardic D., Leung T., and Gaines D.R. Role for standards in assays of botulinum toxins: International collaborative study of three preparations of botulinum type A toxin. Biologicals 31 (2003) 265
33. Sesardic D., Jones R.G.A., Leung T., Alsop T., and Tierney R. Detection of antibodies against botulinum toxins. Mov Disord. 19 8 (2004) S85 Suppl
34. Sharma S.K., and Singh B.R. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins. Biochemistry 43 (2004) 4791
35. Sharma S.K., Ferreira J.L., Eblen B.S., and Whiting R.C. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies. Appl. Environ. Microbiol. 72 (2006) 1231
36. Shone C., Ferreira J., Boyer A., Cirino N., Egan C., Evans E., Kools J., and Sharma S. The 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Neurotoxins. Workshop review: assays and detection. Neurotox. Res. 9 (2006) 205
37. Simpson L.L. Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 167